Literature DB >> 28064219

Active and Passive Immunization Against Staphylococcus aureus Periprosthetic Osteomyelitis in Rats.

Niels H Søe1, Nina Vendel Jensen2, Asger Lundorff Jensen3, Janne Koch4, Steen Seier Poulsen5, Gerald B Pier6, Helle Krogh Johansen7,8.   

Abstract

BACKGROUND/AIM: Staphylococcus aureus infection associated with orthopedic implants cannot always be controlled. We used a knee prosthesis model with implant-related osteomyelitis in rats to explore induction of an effective immune response with active and passive immunization.
MATERIALS AND METHODS: Fifty-two Sprague-Dawley rats were divided into active (N=28) and passive immunization groups (N=24). A bacterial inoculum of 103 S. aureus MN8 was injected into the tibia and the femur marrow before insertion of a non-constrained knee prosthesis in each rat. The active-immunization group received a synthetic oligosaccharide of polysaccharide poly-N-acetylglucosamine (PNAG), 9G1cNH2 and the passive-immunization group received immunization with immunoglobulin from rabbits infected with S. aureus. RESULTS/
CONCLUSION: Active immunization against PNAG significantly reduced the consequences of osteomyelitis infection from PNAG-producing intercellular adhesion (ica+) but not ica- S. aureus. Passive immunization resulted in better clinical assessments in animals challenged with either ica+ or ica- S. aureus, suggesting a lack of specificity in this antiserum. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Osteomyelitis; ica+ strain; ica− strain; immunization; implant-related infection Staphylococcus aureus; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28064219      PMCID: PMC5354146          DOI: 10.21873/invivo.11023

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  28 in total

Review 1.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

Review 2.  Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials.

Authors:  Carla Renata Arciola; Davide Campoccia; Pietro Speziale; Lucio Montanaro; John William Costerton
Journal:  Biomaterials       Date:  2012-06-12       Impact factor: 12.479

Review 3.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

4.  Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Authors:  Santiago M Lattar; Mariángeles Noto Llana; Philippe Denoël; Sophie Germain; Fernanda R Buzzola; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Authors:  David Skurnik; Massimo Merighi; Martha Grout; Mihaela Gadjeva; Tomas Maira-Litran; Maria Ericsson; Donald A Goldmann; Susan S Huang; Rupak Datta; Jean C Lee; Gerald B Pier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

Review 6.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

7.  Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Authors:  Colette Cywes-Bentley; David Skurnik; Tanweer Zaidi; Damien Roux; Rosane B Deoliveira; Wendy S Garrett; Xi Lu; Jennifer O'Malley; Kathryn Kinzel; Tauqeer Zaidi; Astrid Rey; Christophe Perrin; Raina N Fichorova; Alexander K K Kayatani; Tomas Maira-Litràn; Marina L Gening; Yury E Tsvetkov; Nikolay E Nifantiev; Lauren O Bakaletz; Stephen I Pelton; Douglas T Golenbock; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

8.  Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies.

Authors:  Michael Otto
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

9.  Infection control by antibody disruption of bacterial quorum sensing signaling.

Authors:  Junguk Park; Reshma Jagasia; Gunnar F Kaufmann; John C Mathison; Diana I Ruiz; Jason A Moss; Michael M Meijler; Richard J Ulevitch; Kim D Janda
Journal:  Chem Biol       Date:  2007-10

10.  Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation.

Authors:  Kazuaki Matsumoto; Koji Nishi; Mari Kikuchi; Daisuke Kadowaki; Yoshiko Tokutomi; Naofumi Tokutomi; Katsuhide Nishi; Ayaka Suenaga; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2007-07       Impact factor: 2.233

View more
  2 in total

Review 1.  Staphylococcal Biofilms.

Authors:  Michael Otto
Journal:  Microbiol Spectr       Date:  2018-08

2.  Vancomycin-Loaded Collagen/Hydroxyapatite Layers Electrospun on 3D Printed Titanium Implants Prevent Bone Destruction Associated with S. epidermidis Infection and Enhance Osseointegration.

Authors:  Tomáš Suchý; Lucie Vištejnová; Monika Šupová; Pavel Klein; Martin Bartoš; Yaroslav Kolinko; Tereza Blassová; Zbyněk Tonar; Marek Pokorný; Zbyněk Sucharda; Margit Žaloudková; František Denk; Rastislav Ballay; Štefan Juhás; Jana Juhásová; Eva Klapková; Lukáš Horný; Radek Sedláček; Tomáš Grus; Zdeněk Čejka; Zdeněk Čejka; Kateřina Chudějová; Jaroslav Hrabák
Journal:  Biomedicines       Date:  2021-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.